期刊文献+

粪便钙卫蛋白在炎症性肠病中的临床诊断价值 被引量:3

Application of Fecal calprotectin in the clinical diagnosis of inflammatory bowel disease
原文传递
导出
摘要 目的 探讨粪便钙卫蛋白(calprotectin)对炎症性肠病(inflammatory bowel disease,IBD)的临床应用价值.方法 收集结肠镜取病理标本确诊IBD的患者79例,其中溃疡性结肠炎(ulcerative colitis,UC)患者47例、克罗恩病(Crohn's disease,CD)患者32例;腹痛、腹泻等肠道炎症除外IBD患者42例作为疾病对照组;健康体检者34例作为健康对照组,采用ELISA方法检测各组粪便中钙卫蛋白水平.结果 钙卫蛋白在IBD组、疾病对照组和健康对照组中的阳性率分别为57.0%;19.0%;0,IBD组阳性率显著高于其它两组(P<0.05);79例IBD患者粪便钙卫蛋白浓度[(493.86±204.18) μg/g]高于疾病对照组[(71.46 ±60.51) μg/g]和健康对照组[(36.19±13.46) μg/g](P<0.05);IBD活动期钙卫蛋白浓度[(1015.23±324.96)μg/g]显著高于静止期[(52.69±34.71) μg/g](P<0.01).结论 粪便钙卫蛋白检测有助于IBD的早期诊断,并可作为IBD活动性的判断指标,具有临床推广价值. Objective To investigate the clinical application of fecal calprotectin in inflammatory bowel disease (IBD).Methods Colonoscopy took 79 patients with IBD that were diagnosed with pathology,including 47 cases of ulcerative colitis (UC) patients,32 cases of Crohn's disease (CD).Moreover,42 cases of IBD patients without abdominal pain,diarrhea and other intestinal inflammation were used as disease control group,and 34 cases of healthy people were used as healthy control group.The level of fecal calprotectin in each group was detected by enzyme-linked immunosorbent assay (ELISA).Results The positive rate of fecal Calprotectin in IBD group,disease control group and the healthy control group was 57.0%,19.0%,and 0,respectively; each positive rate in IBD group was significantly higher than the other two groups (P 〈 0.05).The serum concentration of fecal calprotectin in IBD group [(493.86 ±204.18) μg/g] was significantly higher than the disease control group [(71.46 ± 60.51) μg/g] and the healthy control group [(36.19 ± 13.46) μg/g] (P 〈 0.05) ; IBD active calprotection [(1015.23 ± 324.96) μg/g] was significantly higher than resting [(52.69 ±34.71) μg/g] (P 〈0.01).Conclusions Fecal calprotectin test benefits early diagnosis of IBD,and may be taken as the diagnostic index of IBD activity.It has extensively clinical value.
出处 《中国医师杂志》 CAS 2013年第8期1022-1024,共3页 Journal of Chinese Physician
基金 基金项目:内蒙古自治区科技攻关资助项目(20070501)
关键词 白细胞L1抗原复合物 粪便 炎性肠疾病 诊断 酶联免疫吸附测定 Leukocyte L1 antigen complex Feces Inflammatory bowel diseases/diagnosis En-zyme-linked immunosorbent assay
  • 相关文献

参考文献10

二级参考文献93

共引文献413

同被引文献30

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部